NCT01829750View on ClinicalTrials.gov

Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease (PERSEUS)

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

September 30, 2016

Conditions
Hypoplastic Left Heart SyndromeSingle Right VentricleSingle Left Ventricle
Interventions
GENETIC

Cardiac progenitor cell infusion

"(Stage 1) Cardiac progenitor cell infusion in patients who assigned as active comparator group~(Stage 2) Rescuing transplantation is applicable in patients, along with their written consent, 4 months after palliations who were allocated as control group in stage 1."

Trial Locations (1)

700-8558

Okayama University, Okayama

All Listed Sponsors
collaborator

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

OTHER

lead

Okayama University

OTHER

NCT01829750 - Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease (PERSEUS) | Biotech Hunter | Biotech Hunter